The Joint Enrollment Pathway is for students who are interested in earning their BSN while still enrolled in their associate degree program. This allows students to earn both degrees at the same time ...

Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering therapies inspired by genetic resilience, today ...

In May 2025, the FDA approved numerous biosimilars as interchangeable with Stelara® (ustekinumab) and Humira® (adalimumab), bringing the total ...

FIL200 was non-inferior to adalimumab in terms of Disease Activity Score in 28 joints with C reactive protein ≤3.2 at week 12 (p<0.001); FIL100 did not achieve non-inferiority. Adverse events and ...

The Food and Drug Administration has designated Hadlima (adalimumab-bwwd) an interchangeable biosimilar to Humira (adalimumab).

All documentation must include the month, date, and year that the vaccine or booster dose was administered. *Please read the compliance form instructions carefully. All students must choose either ...

Some Michigan hospitals are marking up prices by thousands of dollars above what they pay manufacturers for certain prescription drugs, according to a new report from the Michigan Health Purchasers ...

With this approval, YUFLYMA is now fully interchangeable with the reference product, Humira ® (adalimumab), across all marketed dosage forms and strengths. YUFLYMA is a high-concentration, ...

Humira ® (adalimumab), across all marketed dosage forms and strengths. YUFLYMA is a high-concentration, citrate-free biosimilar to Humira, approved for multiple inflammatory indications ...